Global Maternal Pertussis Vaccine for Newborn Protection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 88

Published Date: 21 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Maternal Pertussis Vaccine for Newborn Protection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Maternal Pertussis Vaccine for Newborn Protection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Maternal Pertussis Vaccine for Newborn Protection market size and forecasts, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2019-2030
Global Maternal Pertussis Vaccine for Newborn Protection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2019-2030
Global Maternal Pertussis Vaccine for Newborn Protection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2019-2030
Global Maternal Pertussis Vaccine for Newborn Protection market shares of main players, shipments in revenue ($ Million), sales quantity (Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Maternal Pertussis Vaccine for Newborn Protection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Maternal Pertussis Vaccine for Newborn Protection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Intravacc, Zhifei Biological, Walvax, Minhai Biological, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Maternal Pertussis Vaccine for Newborn Protection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Acellular Pertussis Vaccine
    Whole-cell Pertussis Vaccine

Market segment by Application
    Hospital
    Centers for Disease Control and Prevention
    Others

Major players covered
    GlaxoSmithKline
    Sanofi Pasteur
    Intravacc
    Zhifei Biological
    Walvax
    Minhai Biological

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Maternal Pertussis Vaccine for Newborn Protection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Maternal Pertussis Vaccine for Newborn Protection, with price, sales quantity, revenue, and global market share of Maternal Pertussis Vaccine for Newborn Protection from 2019 to 2024.
Chapter 3, the Maternal Pertussis Vaccine for Newborn Protection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Maternal Pertussis Vaccine for Newborn Protection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Maternal Pertussis Vaccine for Newborn Protection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Maternal Pertussis Vaccine for Newborn Protection.
Chapter 14 and 15, to describe Maternal Pertussis Vaccine for Newborn Protection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Acellular Pertussis Vaccine
        1.3.3 Whole-cell Pertussis Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Centers for Disease Control and Prevention
        1.4.4 Others
    1.5 Global Maternal Pertussis Vaccine for Newborn Protection Market Size & Forecast
        1.5.1 Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (2019-2030)
        1.5.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.1.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GlaxoSmithKline Recent Developments/Updates
    2.2 Sanofi Pasteur
        2.2.1 Sanofi Pasteur Details
        2.2.2 Sanofi Pasteur Major Business
        2.2.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.2.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi Pasteur Recent Developments/Updates
    2.3 Intravacc
        2.3.1 Intravacc Details
        2.3.2 Intravacc Major Business
        2.3.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.3.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Intravacc Recent Developments/Updates
    2.4 Zhifei Biological
        2.4.1 Zhifei Biological Details
        2.4.2 Zhifei Biological Major Business
        2.4.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.4.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Zhifei Biological Recent Developments/Updates
    2.5 Walvax
        2.5.1 Walvax Details
        2.5.2 Walvax Major Business
        2.5.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.5.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Walvax Recent Developments/Updates
    2.6 Minhai Biological
        2.6.1 Minhai Biological Details
        2.6.2 Minhai Biological Major Business
        2.6.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product and Services
        2.6.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Minhai Biological Recent Developments/Updates

3 Competitive Environment: Maternal Pertussis Vaccine for Newborn Protection by Manufacturer
    3.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturer (2019-2024)
    3.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Maternal Pertussis Vaccine for Newborn Protection by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Maternal Pertussis Vaccine for Newborn Protection Manufacturer Market Share in 2023
        3.4.3 Top 6 Maternal Pertussis Vaccine for Newborn Protection Manufacturer Market Share in 2023
    3.5 Maternal Pertussis Vaccine for Newborn Protection Market: Overall Company Footprint Analysis
        3.5.1 Maternal Pertussis Vaccine for Newborn Protection Market: Region Footprint
        3.5.2 Maternal Pertussis Vaccine for Newborn Protection Market: Company Product Type Footprint
        3.5.3 Maternal Pertussis Vaccine for Newborn Protection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
        4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2019-2030)
        4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2019-2030)
        4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Region (2019-2030)
    4.2 North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030)
    4.3 Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030)
    4.4 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030)
    4.5 South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030)
    4.6 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    5.2 Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Type (2019-2030)
    5.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    6.2 Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application (2019-2030)
    6.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Application (2019-2030)

7 North America
    7.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    7.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    7.3 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
        7.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2030)
        7.3.2 North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    8.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    8.3 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
        8.3.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2030)
        8.3.2 Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region
        9.3.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    10.2 South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    10.3 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
        10.3.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2030)
        10.3.2 South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
        11.3.1 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Maternal Pertussis Vaccine for Newborn Protection Market Drivers
    12.2 Maternal Pertussis Vaccine for Newborn Protection Market Restraints
    12.3 Maternal Pertussis Vaccine for Newborn Protection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Maternal Pertussis Vaccine for Newborn Protection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Maternal Pertussis Vaccine for Newborn Protection
    13.3 Maternal Pertussis Vaccine for Newborn Protection Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Maternal Pertussis Vaccine for Newborn Protection Typical Distributors
    14.3 Maternal Pertussis Vaccine for Newborn Protection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
 Table 4. GlaxoSmithKline Major Business
 Table 5. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 6. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. GlaxoSmithKline Recent Developments/Updates
 Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
 Table 9. Sanofi Pasteur Major Business
 Table 10. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 11. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Sanofi Pasteur Recent Developments/Updates
 Table 13. Intravacc Basic Information, Manufacturing Base and Competitors
 Table 14. Intravacc Major Business
 Table 15. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 16. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Intravacc Recent Developments/Updates
 Table 18. Zhifei Biological Basic Information, Manufacturing Base and Competitors
 Table 19. Zhifei Biological Major Business
 Table 20. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 21. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Zhifei Biological Recent Developments/Updates
 Table 23. Walvax Basic Information, Manufacturing Base and Competitors
 Table 24. Walvax Major Business
 Table 25. Walvax Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 26. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Walvax Recent Developments/Updates
 Table 28. Minhai Biological Basic Information, Manufacturing Base and Competitors
 Table 29. Minhai Biological Major Business
 Table 30. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product and Services
 Table 31. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Minhai Biological Recent Developments/Updates
 Table 33. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Manufacturer (2019-2024) & (Dose)
 Table 34. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 35. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 36. Market Position of Manufacturers in Maternal Pertussis Vaccine for Newborn Protection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 37. Head Office and Maternal Pertussis Vaccine for Newborn Protection Production Site of Key Manufacturer
 Table 38. Maternal Pertussis Vaccine for Newborn Protection Market: Company Product Type Footprint
 Table 39. Maternal Pertussis Vaccine for Newborn Protection Market: Company Product Application Footprint
 Table 40. Maternal Pertussis Vaccine for Newborn Protection New Market Entrants and Barriers to Market Entry
 Table 41. Maternal Pertussis Vaccine for Newborn Protection Mergers, Acquisition, Agreements, and Collaborations
 Table 42. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 43. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2019-2024) & (Dose)
 Table 44. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2025-2030) & (Dose)
 Table 45. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2019-2024) & (USD Million)
 Table 46. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2025-2030) & (USD Million)
 Table 47. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Region (2019-2024) & (US$/Dose)
 Table 48. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Region (2025-2030) & (US$/Dose)
 Table 49. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 50. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 51. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Type (2019-2024) & (USD Million)
 Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Type (2025-2030) & (USD Million)
 Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Type (2019-2024) & (US$/Dose)
 Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Type (2025-2030) & (US$/Dose)
 Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application (2019-2024) & (USD Million)
 Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application (2025-2030) & (USD Million)
 Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Application (2019-2024) & (US$/Dose)
 Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Application (2025-2030) & (US$/Dose)
 Table 61. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 62. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 63. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 64. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 65. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2024) & (Dose)
 Table 66. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2025-2030) & (Dose)
 Table 67. North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2024) & (USD Million)
 Table 68. North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2025-2030) & (USD Million)
 Table 69. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 70. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 71. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 72. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 73. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2024) & (Dose)
 Table 74. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2025-2030) & (Dose)
 Table 75. Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2024) & (USD Million)
 Table 76. Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2025-2030) & (USD Million)
 Table 77. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 78. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 79. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 80. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 81. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2019-2024) & (Dose)
 Table 82. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Region (2025-2030) & (Dose)
 Table 83. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2019-2024) & (USD Million)
 Table 84. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Region (2025-2030) & (USD Million)
 Table 85. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 86. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 87. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 88. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 89. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2024) & (Dose)
 Table 90. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2025-2030) & (Dose)
 Table 91. South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2024) & (USD Million)
 Table 92. South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2025-2030) & (USD Million)
 Table 93. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2019-2024) & (Dose)
 Table 94. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Type (2025-2030) & (Dose)
 Table 95. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2019-2024) & (Dose)
 Table 96. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Application (2025-2030) & (Dose)
 Table 97. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2019-2024) & (Dose)
 Table 98. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity by Country (2025-2030) & (Dose)
 Table 99. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2019-2024) & (USD Million)
 Table 100. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Country (2025-2030) & (USD Million)
 Table 101. Maternal Pertussis Vaccine for Newborn Protection Raw Material
 Table 102. Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection Raw Materials
 Table 103. Maternal Pertussis Vaccine for Newborn Protection Typical Distributors
 Table 104. Maternal Pertussis Vaccine for Newborn Protection Typical Customers


List of Figures
 Figure 1. Maternal Pertussis Vaccine for Newborn Protection Picture
 Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type in 2023
 Figure 4. Acellular Pertussis Vaccine Examples
 Figure 5. Whole-cell Pertussis Vaccine Examples
 Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application in 2023
 Figure 8. Hospital Examples
 Figure 9. Centers for Disease Control and Prevention Examples
 Figure 10. Others Examples
 Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity (2019-2030) & (Dose)
 Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Price (2019-2030) & (US$/Dose)
 Figure 15. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Maternal Pertussis Vaccine for Newborn Protection by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Maternal Pertussis Vaccine for Newborn Protection Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Maternal Pertussis Vaccine for Newborn Protection Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Type (2019-2030) & (US$/Dose)
 Figure 30. Global Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2019-2030)
 Figure 32. Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Application (2019-2030) & (US$/Dose)
 Figure 33. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Maternal Pertussis Vaccine for Newborn Protection Consumption Value (2019-2030) & (USD Million)
 Figure 73. Maternal Pertussis Vaccine for Newborn Protection Market Drivers
 Figure 74. Maternal Pertussis Vaccine for Newborn Protection Market Restraints
 Figure 75. Maternal Pertussis Vaccine for Newborn Protection Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Maternal Pertussis Vaccine for Newborn Protection in 2023
 Figure 78. Manufacturing Process Analysis of Maternal Pertussis Vaccine for Newborn Protection
 Figure 79. Maternal Pertussis Vaccine for Newborn Protection Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GlaxoSmithKline
Sanofi Pasteur
Intravacc
Zhifei Biological
Walvax
Minhai Biological

Related Reports

Global Maternal Pertussis Vaccine for Newborn Protection Supply, Demand and Key Producers, 2024-2030

Global Maternal Pertussis Vaccine for Newborn Protection Supply, Demand and Key Producers, 2024-2030

date 21 Aug 2024

date Pharma & Healthcare

The global Maternal Pertussis Vaccine for Newborn Protection market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Product Tags

Maternal Pertussis Vaccine for Newborn Protection

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>